Clobazam Suspension
Product Images NDC 59651-401

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 59651-401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Clobazam Fig1)

FDA Label Image

Figure-10 (Clobazam Fig10)

FDA Label Image

Figure-11 (Clobazam Fig11)

FDA Label Image

Fig12 (Clobazam Fig12)

Fig12 (Clobazam Fig12)
Clobazam is an oral suspension medication that comes in a 2.5 mg/mL concentration. Each mL contains 2.5 mg of Clobazam. The usual dosage must be checked in the package insert. This medication must be kept in its original container in an upright position and used within 90 days of first opening. The medication must be stored between 20°C to 25°C. The product comes with two 10 mL syringes for 120 mL administration. It is only for oral administration and must be shaken well before use. The medication guide must be dispensed by the pharmacist to each patient. This medication is distributed by Aurobindo Pharma USA, Inc. and made in India.*
FDA Label Image

Fig13 (Clobazam Fig13)

Fig13 (Clobazam Fig13)
This is a description for a medication called Clobazam Oral Suspension. The package comes with 120mL and each mL contains 25mg of Gitazam. The product should be stored and dispensed in an upright position and shaken before each use. The medication is provided with a Medication Guide and Instructions for Use, and it is only meant for oral administration. The medication is distributed by Aurobindo Pharma USA, located on Princeton-Hightstown Road in East Windsor, and it is made in India. The code for the medication is APTRUGSDAZ015.*
FDA Label Image

Figure (Clobazam Fig2)

FDA Label Image

Figure-3 (Clobazam Fig3)

Figure-3 (Clobazam Fig3)
The text is not-available as it is incomplete and doesn't provide enough context to generate a useful description.*
FDA Label Image

Figure-4 (Clobazam Fig4)

FDA Label Image

Figure-5 (Clobazam Fig5)

FDA Label Image

Figure-6 (Clobazam Fig6)

Figure-6 (Clobazam Fig6)
This text is a list of two words related to medical syringes - "Dosage indicators" and "Plunger" with a slash and "Edge of Plunger Barrel" listed below it. It appears to be instructions or key features of how to use a syringe.*
FDA Label Image

Figure-7 (Clobazam Fig7)

FDA Label Image

Figure-4 (Clobazam Fig8)

FDA Label Image

Figure-9 (Clobazam Fig9)

FDA Label Image

Chemical Structure (Clobazam Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.